Cholangiocarcinoma: An-eight-year experience in a tertiary-center in Iran

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5381-5384

  Mohammad Alizadeh, Amir Houshang ^a   Ghobakhlou, Mehdi ^a   Shalmani, Hamid Mohaghegh ^a   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cholangiocarcinoma; Clinical features; Diagnosis; ERCP; MRCP; Risk factors; Survival; Teatment

Indexed keywords

EID: 84874059419     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5381     Document Type: Article

References (20)

1. Ahrendt SA, Pitt HA (2001). Biliary tract. In: Townsend C, Eds. Sabiston Textbook of Surgery. Philadelphia, W.B. Saunders Company pp 1076-1111.
2. Alvaro D, Mancino MG (2008). New insights on the molecular and cell biology of human cholangiopathies. Mol Aspects Med, 29, 50-7.
3. Blechacz B, Gores GJ (2008). Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology, 48, 308-21.
4. Burke EC, Jarnagin WR, Hochwald SN, et al (1998). Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg, 228, 385-94.
5. Burak K, Angulo P, Pasha TM, et al (2004). Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol, 99, 523-6.
6. Boberg KM, Bergquist A, Mitchell S, et al (2002). Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol, 37, 1205-11.
7. Carriaga MT, Henson DE (1995). Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer, 75, 171-90.
8. Cho SY, Park SJ, Kim SH, et al (2010). Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol, 17, 1823-30.
9. Khan SA, Davidson BR, Goldin R, et al (2002). Guidelines for the diagnosis and management of cholangiocarcinoma. Gut, 51, 1-I9.
10. Jan YY, Jeng LB, Hwang TL, et al (1996). Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma. Hepatogastroenterology, 43, 614-19.
11. Park J, Kim MH, Kim KP, et al (2009). Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study. Gut Liver, 3, 298-305.
12. Nagorney DM, Donohue JH, Farnell MB, et al (1993). Outcomes after curative resections of cholangiocarcinoma. Arch Surg, 128, 871-7.
13. Nakeeb A, Pitt HA, Sohn TA, et al (1996). Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg, 224, 463-73.
14. Shaib YH, El-Serag HB, Davila JA, et al (2002). Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology, 128, 620-6.
15. Shaib YH, El-Serag HB, Davila JA, et al (2005). Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology, 128, 620-6
16. Shaib Y, El-Serag HB (2004). The epidemiology of cholangiocarcinoma. Semin Liver Dis, 24, 115-25.
17. Suh KS, Roh HR, Koh YT, et al (2000). Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology, 31, 12-17.
18. Vauthey JN, Blumgart LH (1994). Recent advances in the management of cholangiocarcinomas. Semin Liver Dis, 14, 109-14.
19. Welzel TM, Graubard BI, El-Serag HB, et al (2007). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol, 5, 1221-8.
20. Yachimski P, Pratt DS (2008). Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients. J Clin Gastroenterol, 42, 178-90.